Deprescription in Advanced Cancer Patients [PDF]
Pharmacy (Basel, Switzerland), 2018 The use of multiple drugs is often referred to as polypharmacy, although this term has not been precisely defined. Frequently, drugs are used unwisely in multiple combinations increasing the risk of adverse reactions, or for the long-term prevention of ...
Ferraz Gonçalves
exaly +5 more sources
Impact of CYP2D6 genotype on opioid use disorder deprescription: an observational prospective study in chronic pain with sex-differences [PDF]
Frontiers in Pharmacology, 2023 Introduction: Opioid deprescription is the process of supervised tapering and safe withdrawal when a potentially inappropriate use is detected. This represents a challenge in chronic non-cancer pain (CNCP) patients who may respond differently to the ...
Javier Muriel +2 more
exaly +5 more sources
An integrative systematic review of nurses’ involvement in medication deprescription in long-term healthcare settings for older people [PDF]
Therapeutic Advances in Drug SafetyBackground: Deprescription of medications for older people in long-term care settings is crucial to enhance medication safety by reducing polypharmacy and minimizing related adverse events.
Mojtaba Vaismoradi
exaly +4 more sources
Evidence for deprescription in primary care through an umbrella review [PDF]
BMC Family Practice, 2020 Background There is a high prevalence of potentially inappropriate prescriptions in primary care. This is associated with more frequent adverse events, lower quality of life and more frequent visits to hospital accident & emergency departments.
Antonio Olry de Labry Lima
exaly +7 more sources
Proton pump inhibitor deprescription: A rapid review [PDF]
Brazilian Journal of Pharmaceutical Sciences, 2022 Proton pump inhibitors (PPI) are drugs that suppress gastric acid secretion. Its use, without support from scientific evidence, can contribute to polypharmacy, lead to drug interactions and, in the long term, cause serious adverse reactions.
Renata Rodriguez Imparato +1 more
doaj +5 more sources
Long-term deprescription in chronic pain and opioid use disorder patients: Pharmacogenetic and sex differences [PDF]
Acta Pharmaceutica, 2023 More than half of patients with opioid use disorder for chronic non-cancer pain (CNCP) reduced their dose through a progressive opioid withdrawal supported by a rotation to buprenorphine and/or tramadol.
Muriel Javier +6 more
doaj +5 more sources
Improving Pharmacists’ Targeting of Patients for Medication Review and Deprescription [PDF]
Pharmacy, 2018 Background: In an acute hospital setting, a multi-disciplinary approach to medication review can improve prescribing and medicine selection in patients with frailty.
Vanessa Marvin +4 more
doaj +11 more sources
Frontiers in NutritionBackgroundCost, scalability, and durability represent major challenges to the implementation of intensive lifestyle treatments for obesity and diabetes.
Laura Buchanan +8 more
exaly +5 more sources
Deprescription: a global need to rationalize drug prescribing [PDF]
International Journal of Basic & Clinical Pharmacology, 2020 Appropriate prescribing and deprescription of unwanted medicines are a global concern. Polypharmacy is common in old age due to multiple comorbidities.
Das, Biswadeep +2 more
core +3 more sources
Impediments to deprescription in Brazil: overview from a panel of geriatrics experts
Geriatrics Gerontology and Aging, 2022 Objectives: To identify impediments to deprescription among older adults from the perspective of a panel of Brazilian geriatricians. Methods: The Delphi method was used to obtain a consensus among Brazilian geriatricians about the factors that influence ...
Juliana Junqueira Marques Teixeira +2 more
exaly +3 more sources